3rd-Party Payer Class Certified In Zyprexa MDL

Law360, New York (September 8, 2008, 12:00 AM EDT) -- A federal judge has granted certification to a class of third-party payers suing for overpayment on Eli Lilly and Co.'s anti-psychotic Zyprexa, but has denied certification for individual payer claims.

In the U.S. District Court for the Eastern District of New York, Judge Jack Weinstein set in motion on Friday a class action alleging that Lilly violated the federal Racketeer Influenced and Corrupt Organizations Act.

Judge Weinstein declined to rule on a class certification on state-based claims.

The litigation is a consolidation of dozens of suits...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.